Back

Eli Lilly shares fall 2% as healthcare stocks lead market declines

Verifying
  • Eli Lilly shares fell as broader market and healthcare-sector weakness pressured large-cap stocks.
  • 1.7%: Healthcare was Tuesday’s weakest S&P 500 sector.
  • Novartis’ HARBOR trial for del-desiran failed to meet its primary endpoint.
The information on this website is generated using AI and we cannot guarantee its accuracy. Please use it as reference information only.